Shortage of Remdesivir biggest hindrance in fight against Covid-19 in J&K
Unlike other parts of the country, the Union Territory is neither facing a shortage of beds nor of oxygen in all the dedicated COVID hospitals but the patients, across Jammu and Kashmir, are suffering due to the non-availability of Remdesivir, as per the demand.
Admitting that like other parts of the country, J&K is also facing a shortage of Remdesivi, Dr. Yashpal Sharma, Managing Director of the J&K Medical Supplies Corporation Limited (JKMSCL) was hopeful that very soon adequate supply of the drug would be made in all hospitals of J&K.
Strict action against hoarding of COVID related drugs, Remdesivir: Div Com-J
Daily log to be submitted by UT Drug Controller
JAMMU Tawi, APRIL 27: Divisional Commissioner, Jammu, Dr Raghav Langer today reviewed the stock and supply position of essential drugs for the treatment of Covid positive patients, here at a meeting at the Drug Controller Office, Jammu.
The meeting was attended by Deputy Commissioner Jammu, Anshul Garg; MD National Health Mission, Yasin Choudhary; UT Drugs Controller J&K, Lotika Khajuria, MD JKMSCL Dr Yashpal Sharma besides Assistant Drugs Controllers, DCOs and other concerned officers.
UT Drugs Controller apprised the Div Com that the Drug Controller General of India has designated Remdesivir as a institutional supply only drug in view of the emerging Covid situation and a quota of 10,500 vials per week has been fixed for J&K by GoI, at present.